Research News and Research

RSS

Hunt in pairs to find a suitable date

Looking for success on the dating scene? MIT Sloan Assistant Professor Joshua M. Ackerman suggests it might be a good idea to bring a friend.

20 Oct 2009

RA patients who adhere to their prescription drug regimen have better outcome: Study

Rheumatoid arthritis (RA) patients who regularly adhere to their prescription drug regimen have fewer emergency room and doctor visits and incur lower medical costs, according to research presented today by Medco Health Solutions, Inc. at the American College of Rheumatology's Annual Meeting in Philadelphia.

20 Oct 2009

TV viewing has no significant impact on people's perceptions of global warming

Worried about climate change and want to learn more? You probably aren't watching television then. A new study by George Mason University Communication Professor Xiaoquan Zhao suggests that watching television has no significant impact on viewers' knowledge about the issue of climate change. Reading newspapers and using the web, however, seem to contribute to people's knowledge about this issue.

20 Oct 2009

Women Thrive commends subcommittee hearing on crisis of violence against women

DC-based Women Thrive hails the upcoming subcommittee hearing at the House Foreign Affairs Committee on the crisis of violence against women and girls globally.

20 Oct 2009

Fluarix seasonal influenza vaccine approved by the FDA

The U.S. Food and Drug Administration today approved use of the seasonal influenza vaccine Fluarix for children ages 3 years to 17 years. Previously, this vaccine, which contains inactivated (killed) influenza A and B viruses, had been approved for use in adults, ages 18 years and older.

20 Oct 2009

Highly educated women deal less well with psychological aspects of breast cancer

Well-educated women and those who live alone are emotionally the hardest hit by breast cancer, according to the findings of a new Australian study announced during October's Breast Cancer Awareness Month.

20 Oct 2009

Tempur-Pedic Hugs Back campaign to help fund research for pancreatic cancer

Tempur-Pedic International Inc. (NYSE: TPX), the leading manufacturer, marketer and distributor of premium mattresses and pillows worldwide, today announces the Tempur-Pedic Hugs Back campaign, featuring a limited edition version of the company's popular My Tempur-Pedic Teddy Bear®.

20 Oct 2009

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that during the A/H1N1 (swine flu) pandemic, GlaxoSmithKline could see its Relenza sales increase if Tamiflu-resistant strains of the virus spread. GlaxoSmithKline recently signed A/H1N1 2009 vaccine contracts with various governments for more than $3 billion and is donating supplies to less wealthy nations, ensuring that the company strikes a balance between profit and public health concerns.

20 Oct 2009

Springer to launch "Translational Stroke Research" journal

Springer is launching a new quarterly journal Translational Stroke Research, which aims to help translate scientific discoveries from basic stroke research into the development of new strategies for prevention, assessment, treatment and repair after stroke and other forms of neurotrauma. The first issue will appear in March 2010.

20 Oct 2009

Age, gender and malignancies pose significant risk factors for TIVADs survival

It is common practice to insert totally implantable venous access devices (TIVADs) in cancer patients beginning a course of chemotherapy to eliminate potential peripheral venous access problems; however, risk factors impacting the survival of TIVADs remain unclear.

20 Oct 2009

ECRI Institute reports increase in request for medical technology acquisition support from its members

ECRI Institute(R), an independent nonprofit that researches the best approaches to improve patient care and offers procurement support to more than 2,000 U.S. hospitals, reports a significant increase in requests by its members for medical technology acquisition support, a strong signal that the economy may be improving. ECRI Institute member hospital research requests typically precede medical capital technology purchases.

20 Oct 2009

Academic medical centers do not always practice the values they preach

As the national conversation about healthcare reform engages millions of Americans, a new Brandeis study sheds light on the values of medical faculty who train the nation's physicians and lead in health care and research in the U.S.

20 Oct 2009

Stemedica completes pre-IND meeting with the FDA concerning allogeneic mesenchymal bone marrow cells

Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that it completed its pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding a proposed IND (Investigative New Drug) to evaluate the safety and efficacy of Stemedica's high potency proprietary allogeneic mesenchymal bone marrow-derived stem cells (adult human) as a treatment for ischemic stroke.

20 Oct 2009

Higher status positions can have negative impact on personal health

Being at the top has its perks, but new UofT research shows people in positions of authority at work are more likely to experience certain psychological and physical problems that can undermine the health benefits associated with job authority.

20 Oct 2009

Investment opportunities in the global patient monitoring market thru 2015

MarketResearch.com has announced the addition of Global Markets Direct's new report "Global Patient Monitoring Investment Opportunities, Analysis and Forecasts to 2015," to their collection of Patient Monitoring market reports.

20 Oct 2009

Rexahn Pharmaceuticals announces positive results from Phase IIa Serdaxin clinical study

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company focused on developing multi-indication therapeutics in CNS and oncology, today announced top-line results from a Phase IIa clinical study of Serdaxin™, its major depressive disorder (MDD) drug candidate.

20 Oct 2009

Menarini granted exclusive European licence rights to Ipsen's Adenuric

Ipsen, an innovation-driven global specialty pharmaceutical group, announced an agreement whereby Ipsen grants the Menarini Group the exclusive licence rights to Adenuric® (febuxostat) in 41 countries. Ipsen retains co-promotion rights for Adenuric® in France.

20 Oct 2009

Virtual Reality Exposure Treatment to help tackle driving phobias

Researchers at The University of Manchester have recruited volunteers with a variety of driving phobias to test whether virtual reality can be used alongside conventional psychological therapies to help tackle their fears.

From The University of Manchester 20 Oct 2009

Origene Technologies' acquisition of Marligen Biosciences reinforces its leading position in the bio-medical research industry

OriGene Technologies, Inc. today announced the acquisition of Marligen Biosciences, Inc., a provider of cutting-edge multiplex assays for the Luminex xMAP(R) platform for protein and gene expression profiling assays and testing services, and DNA and RNA purification kits.

20 Oct 2009

New research emphasizes benefits of exercise on brain and related disorders

Research presented today at Neuroscience 2009, the annual meeting of the Society for Neuroscience (SfN) and the world's largest source of emerging news about brain science and health, provides a better understanding of the brain, nervous system, and related disorders.

20 Oct 2009

Research News and Research

Hunt in pairs to find a suitable date

RA patients who adhere to their prescription drug regimen have better outcome: Study

TV viewing has no significant impact on people's perceptions of global warming

Women Thrive commends subcommittee hearing on crisis of violence against women

Fluarix seasonal influenza vaccine approved by the FDA

Highly educated women deal less well with psychological aspects of breast cancer

Tempur-Pedic Hugs Back campaign to help fund research for pancreatic cancer

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Springer to launch "Translational Stroke Research" journal

Age, gender and malignancies pose significant risk factors for TIVADs survival

ECRI Institute reports increase in request for medical technology acquisition support from its members

Academic medical centers do not always practice the values they preach

Stemedica completes pre-IND meeting with the FDA concerning allogeneic mesenchymal bone marrow cells

Higher status positions can have negative impact on personal health

Investment opportunities in the global patient monitoring market thru 2015

Rexahn Pharmaceuticals announces positive results from Phase IIa Serdaxin clinical study

Menarini granted exclusive European licence rights to Ipsen's Adenuric

Virtual Reality Exposure Treatment to help tackle driving phobias

Origene Technologies' acquisition of Marligen Biosciences reinforces its leading position in the bio-medical research industry

New research emphasizes benefits of exercise on brain and related disorders

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms